These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37517689)

  • 21. Review and Validation of Bayesian Dose-Optimizing Software and Equations for Calculation of the Vancomycin Area Under the Curve in Critically Ill Patients.
    Turner RB; Kojiro K; Shephard EA; Won R; Chang E; Chan D; Elbarbry F
    Pharmacotherapy; 2018 Dec; 38(12):1174-1183. PubMed ID: 30362592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients.
    Ishigo T; Ibe Y; Fujii S; Kazuma S; Aigami T; Kashiwagi Y; Takada R; Takahashi S; Fukudo M; Toda T
    J Infect Chemother; 2023 Aug; 29(8):769-777. PubMed ID: 37150254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram.
    Baptista JP; Roberts JA; Sousa E; Freitas R; Deveza N; Pimentel J
    Crit Care; 2014 Dec; 18(6):654. PubMed ID: 25475123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.
    Finch NA; Zasowski EJ; Murray KP; Mynatt RP; Zhao JJ; Yost R; Pogue JM; Rybak MJ
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precision dosing of vancomycin: in defence of AUC-guided therapy in children.
    Murphy ME; Tang Girdwood S; Goldman JL; Scheetz MH; Downes KJ
    J Antimicrob Chemother; 2021 Sep; 76(10):2494-2497. PubMed ID: 34096598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficiency of dosing software using Bayesian forecasting in achieving target antibiotic exposures in critically ill patients, a prospective cohort study.
    Chai MG; Roberts JA; Kelly CF; Ungerer JPJ; McWhinney BC; Lipman J; Farkas A; Cotta MO
    Anaesth Crit Care Pain Med; 2023 Dec; 42(6):101296. PubMed ID: 37579945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients.
    Pea F; Furlanut M; Negri C; Pavan F; Crapis M; Cristini F; Viale P
    Antimicrob Agents Chemother; 2009 May; 53(5):1863-7. PubMed ID: 19223642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vancomycin is commonly under-dosed in critically ill children and neonates.
    Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
    Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An area under curve-based nomogram to predicts vancomycin-associated nephrotoxicity in critically ill patients: a retrospective cohort study].
    Wang JL; Xue M; Wang HF; Huang LL; Li Q; Xu JY; Xie JF; Huang YZ
    Zhonghua Nei Ke Za Zhi; 2022 Mar; 61(3):291-297. PubMed ID: 35263970
    [No Abstract]   [Full Text] [Related]  

  • 31. Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens.
    Roberts JA; Taccone FS; Udy AA; Vincent JL; Jacobs F; Lipman J
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2704-9. PubMed ID: 21402850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of vancomycin protein binding on target attainment in critically ill children: back to the drawing board?
    De Cock PA; Desmet S; De Jaeger A; Biarent D; Dhont E; Herck I; Vens D; Colman S; Stove V; Commeyne S; Vande Walle J; De Paepe P
    J Antimicrob Chemother; 2017 Mar; 72(3):801-804. PubMed ID: 27999035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Cho YJ; Corley A; Diehl A; Gilder E; Jakob SM; Kim HS; Levkovich BJ; Lim SY; McGuinness S; Parke R; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Fraser JF; Shekar K; Roberts JA;
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0137721. PubMed ID: 34633852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of model-informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis.
    Frymoyer A; Schwenk HT; Brockmeyer JM; Bio L
    Pharmacotherapy; 2023 Oct; 43(10):1007-1014. PubMed ID: 37401162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients.
    Lin H; Yeh DD; Levine AR
    Crit Care; 2016 Jul; 20(1):205. PubMed ID: 27363312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin pharmacokinetics in critically ill neonates receiving extracorporeal membrane oxygenation.
    An SH; Lee EM; Kim JY; Gwak HS
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e25-e29. PubMed ID: 32296501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of a precision dosing software program for predicting antibiotic concentrations in critically ill patients.
    Chai MG; Roberts JA; Farkas A; Cotta MO
    J Antimicrob Chemother; 2023 Feb; 78(2):354-358. PubMed ID: 36454242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant
    Covvey JR; Erickson O; Fiumara D; Mazzei K; Moszczenski Z; Slipak K; Nemecek BD; Zimmerman DE; Guarascio AJ
    Ann Pharmacother; 2020 Jul; 54(7):644-651. PubMed ID: 31888350
    [No Abstract]   [Full Text] [Related]  

  • 39. Population Pharmacokinetics and Dose Optimization of Vancomycin in Critically Ill Children.
    Sridharan K; Abbasi MY; Mulubwa M
    Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):539-546. PubMed ID: 34156647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC24 Target in Critically Ill Patients.
    Rao Z; Guo SM; Wei YM
    Chemotherapy; 2024; 69(1):49-55. PubMed ID: 37591210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.